- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Cohance Lifesciences Limited — Updates, 18-09-2025: General Updates
18-09-2025 | 11:37 pm
18-09-2025 | 11:37 pm
Cohance addressed USFDA concerns regarding 6 observations at its Hyderabad FDF unit, submitting a corrective plan. This facility's US revenues were <2% of consolidated, with EBITDA <1%, implying no material financial impact.
No comments yet. Be the first to comment!